Anchor Therapeutics Inc.Product Market 2014 Pipeline Review

1
Ascepion Pharmaceuticals, Inc. - Product Pipeline
Review - 2014 www.bigmarketresearch.com
2
Acquired (Autoimmune) Hemolytic Anemia
Report Description
Summary Global Markets Directs, Ascepion
Pharmaceuticals, Inc. - Product Pipeline Review -
2014, provides an overview of the Ascepion
Pharmaceuticals, Inc.s pharmaceutical research
and development focus. This report provides
comprehensive information on the current
therapeutic developmental pipeline of Ascepion
Pharmaceuticals, Inc.s, complete with
comparative analysis at various stages,
therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA)
and molecule type. It also reviews latest
updates, and featured news and press releases,
along with special features on late-stage and
discontinued projects. Get More Details At
http//www.bigmarketresearch.com/ascepion-pharmace
uticals-inc-product-pipeline-review-2014-market
3
Report Description
Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team.
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease.
4
Report Description
Scope - The report provides brief overview of
Ascepion Pharmaceuticals, Inc. including business
description, key information and facts, and its
locations and subsidiaries - The report reviews
current pipeline of Ascepion Pharmaceuticals,
Inc.s human therapeutic division and enlists all
their major and minor projects - The report
features product description and descriptive
mechanism of action for key pipeline products
along with the products developmental history
and major milestones - Special feature on
out-licensed and partnered product portfolio -
The report summarizes all the dormant and
discontinued pipeline projects - Latest company
statement - Latest news and deals relating to
the Ascepion Pharmaceuticals, Inc.s pipeline
products Enquiry about Report _at_
http//www.bigmarketresearch.com/report-enquiry/15
2190
5
Report Description
Reasons to buy - Evaluate Ascepion
Pharmaceuticals, Inc.s strategic position with
total access to detailed information on its
product pipeline - Assess the growth potential of
Ascepion Pharmaceuticals, Inc. in its therapy
areas of focus - Identify new drug targets and
therapeutic classes in the Ascepion
Pharmaceuticals, Inc.s RD portfolio and develop
key strategic initiatives to reinforce pipeline
in those areas - Exploit in-licensing
opportunities by identifying windows of
opportunity to fill portfolio gaps - Develop
strategic initiatives by understanding the focus
areas of Ascepion Pharmaceuticals, Inc. and
exploit collaboration and partnership
opportunities - Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage
6
Report Description
Reasons to buy - Plan mergers and acquisitions
effectively by identifying the most promising
pipeline of Ascepion Pharmaceuticals, Inc. -
Develop and design in-licensing and out-licensing
strategies by identifying prospective partners
with the most attractive projects to enhance and
expand business potential and scope - Explore the
dormant and discontinued projects of Ascepion
Pharmaceuticals, Inc. and identify potential
opportunities in those areas - Avoid Intellectual
Property Rights related issues
7
Table Of Content

• List of Tables
• List of Figures
• Ascepion Pharmaceuticals, Inc. Snapshot
• Ascepion Pharmaceuticals, Inc. Overview
• Key Information
• Key Facts
• Ascepion Pharmaceuticals, Inc. - Research and
  Development Overview
• Key Therapeutic Areas
• Ascepion Pharmaceuticals, Inc. - Pipeline Review
• Pipeline Products by Stage of Development
• Pipeline Products - Monotherapy
• Ascepion Pharmaceuticals, Inc. - Pipeline
  Products Glance
• Ascepion Pharmaceuticals, Inc. - Early Stage
  Pipeline Products
• Preclinical Products/Combination Treatment
  Modalities
• Get complete TOC here _at_ http//www.bigmarketresear
  ch.com/ascepion-pharmaceuticals-inc-product-pipeli
  ne-review-2014-market

8
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/ascepion-pharmace
uticals-inc-product-pipeline-review-2014-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
sales_at_bigmarketresearch.com